Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...

Made Scientific's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.

The two designed compounds, dubbed NG1 and DN1, effectively treated N. gonorrhoeae and S. aureus respectively in preclinical models.

PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the CDC7 inhibitor died in a Phase I trial.

Peptidoglycan hydrolases killed living bacteria, opening the door for further research into the interplay between archaea and bacteria.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.